Literature DB >> 322655

Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q.

K B Reid, R B Sim, A P Faiers.   

Abstract

1. A fragment of subcomponent C1q, which contained all the collagen-like features present in the intact molecule, was isolated by pepsin digestion as described by Reid [Biochem. J. (1976) 155, 5-17]. 2. The pepsin-derived fragment of subcomponent C1q did not bind to antibody-coated erythrocytes under conditions where complete binding of sub-component C1q took place. 3. The peptic fragment blocked the reconstitution of C1 haemolytic activity by competing with intact subcomponent C1q in the utilization of a mixture of the other two subcomponents, C1r and C1s. 4. Reduction and alkylation of the interchain disulphide bonds in the pepsin fragment did not markedly affect its inhibitory effect, whereas heating at 56 degrees C for 30min completely abolished the effect. 5. Lathyritic rat skin collagen and CNBr-derived peptides of pig type II collagen showed no ability to mimic the inhibitory effect of the pepsin fragment when tested over the same concentration range as used for the peptic fragment. 6. The peptic fragment was unable to block efficiently the reconstitution of C1 haemolytic activity unless it was added to the mixture of subcomponents C1r and C1s before the attempt to reconstitute C1 haemolytic activity, in solution, or on the surface of antibody-coated erythrocytes. 7. Evidence was obtained that suggested that subcomponent C1q bound the subcomponent C1r-C1s complex more efficiently when the subcomponent C1q was bound to antibody than when it was free in solution.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 322655      PMCID: PMC1164501          DOI: 10.1042/bj1610239

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Complement fixation by antibody fragments.

Authors:  A TARANTA; E C FRANKLIN
Journal:  Science       Date:  1961-12-15       Impact factor: 47.728

2.  Isolation and comparison of the proenzyme and activated forms of the human serum complement subcomponents C1r and C1s.

Authors:  R B Sim; R R Porter
Journal:  Biochem Soc Trans       Date:  1976       Impact factor: 5.407

3.  Chemical analysis and electron microscopy studies of human C1q prepared by different methods.

Authors:  H R Knobel; W Villiger; H Isliker
Journal:  Eur J Immunol       Date:  1975-01       Impact factor: 5.532

4.  C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.

Authors:  J L Wautier; H Souchon; L C Solal; A P Peltier; J P Caen
Journal:  Immunology       Date:  1976-10       Impact factor: 7.397

5.  Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin.

Authors:  B Brodsky-Doyle; K R Leonard; K B Reid
Journal:  Biochem J       Date:  1976-11       Impact factor: 3.857

6.  The unactivated form of the first component of human complement, C1.

Authors:  I Gigli; R R Porter; R B Sim
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

7.  Enzymatic digestion of the first component of human complement (C1q).

Authors:  H R Knobel; C Heusser; M L Rodrick; H Isliker
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

8.  C'-1 fixation by human isoagglutinins: fixation of C'-1 by gamma-G and gamma-M but not by gamma-A antibody.

Authors:  T Ishizaka; K Ishizaka; T Borsos; H Rapp
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

9.  Ultrastructure of the human complement component, Clq (negative staining-glutamine synthetase-biologically active Clq).

Authors:  E Shelton; K Yonemasu; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

10.  Chromatographic resolution of the first component of human complement into three activities.

Authors:  I H LEPOW; G B NAFF; E W TODD; J PENSKY; C F HINZ
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more
  24 in total

1.  Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.

Authors:  Ming Li; Rahasson R Ager; Deborah A Fraser; Natalia O Tjokro; Andrea J Tenner
Journal:  Mol Immunol       Date:  2008-04-08       Impact factor: 4.407

2.  The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane.

Authors:  J F Bohnsack; A J Tenner; G W Laurie; H K Kleinman; G R Martin; E J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties.

Authors:  S J Perkins
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

4.  Ultrastructure and composition of bovine conglutinin.

Authors:  C J Strang; H S Slayter; P J Lachmann; A E Davis
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

5.  Binding of aggregated human gamma globulin by Raji cells: C1q will enhance only if it is dissociated from the C1 macromolecular complex.

Authors:  U Manthei; R C Strunk
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

Review 6.  The chemistry and biology of complement receptors.

Authors:  R D Schreiber
Journal:  Springer Semin Immunopathol       Date:  1984

7.  Analysis of human C1q by combined bottom-up and top-down mass spectrometry: detailed mapping of post-translational modifications and insights into the C1r/C1s binding sites.

Authors:  Delphine Pflieger; Cédric Przybylski; Florence Gonnet; Jean-Pierre Le Caer; Thomas Lunardi; Gérard J Arlaud; Régis Daniel
Journal:  Mol Cell Proteomics       Date:  2009-12-14       Impact factor: 5.911

8.  Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization.

Authors:  B Ghebrehiwet; L Silvestri; C McDevitt
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

9.  Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.

Authors:  H Jiang; T F Lint; H Gewurz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

10.  Engineering novel complement activity into a pulmonary surfactant protein.

Authors:  Umakhanth Venkatraman Girija; Christopher Furze; Julia Toth; Wilhelm J Schwaeble; Daniel A Mitchell; Anthony H Keeble; Russell Wallis
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.